{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:50:07Z","timestamp":1791078607327,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.expneurol.2013.08.007","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T03:34:47Z","timestamp":1377833687000},"page":"144-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["The absence of indoleamine 2,3-dioxygenase expression protects against NMDA receptor-mediated excitotoxicity in mouse brain"],"prefix":"10.1016","volume":"249","author":[{"given":"G.","family":"Mazarei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.P.","family":"Budac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.R.","family":"Leavitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2013.08.007_bb0005","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1471-4159.2009.05893.x","article-title":"On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo","volume":"109","author":"Amori","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jri.2003.11.003","article-title":"Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific","volume":"61","author":"Baban","year":"2004","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0015","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s007020070026","article-title":"Kynurenic acid metabolism in the brain of HIV-1 infected patients","volume":"107","author":"Baran","year":"2000","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0020","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/321168a0","article-title":"Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid","volume":"321","author":"Beal","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2013.08.007_bb0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1179\/174329210X12650506623645","article-title":"Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease","volume":"15","author":"Bonda","year":"2010","journal-title":"Redox Rep."},{"issue":"11","key":"10.1016\/j.expneurol.2013.08.007_bb0225","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cub.2011.04.028","article-title":"The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease","volume":"21","author":"Campesan","year":"2011","journal-title":"Curr. Biol."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0035","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jnr.1244","article-title":"NMDA receptor function in mouse models of Huntington disease","volume":"66","author":"Cepeda","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0040","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s12640-009-9129-7","article-title":"The kynurenine pathway and inflammation in amyotrophic lateral sclerosis","volume":"18","author":"Chen","year":"2010","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0045","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1128\/IAI.73.8.5249-5251.2005","article-title":"Prolonged survival of a murine model of cerebral malaria by kynurenine pathway inhibition","volume":"73","author":"Clark","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0050","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1111\/j.1460-9568.2007.05838.x","article-title":"Altered kynurenine metabolism correlates with infarct volume in stroke","volume":"26","author":"Darlington","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0055","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1742-2094-8-88","article-title":"HIV-1 Tat activates indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures in a p38 mitogen-activated protein kinase-dependent manner","volume":"8","author":"Fu","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2013.08.007_bb0060","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF00964611","article-title":"l-Kynurenine: its synthesis and possible regulatory function in brain","volume":"5","author":"G\u00e1l","year":"1980","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0065","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","article-title":"Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin","volume":"125","author":"Graham","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2013.08.007_bb0080","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1046\/j.1460-9568.1999.00806.x","article-title":"3-Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum","volume":"11","author":"Guidetti","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0075","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.nbd.2004.07.006","article-title":"Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease","volume":"17","author":"Guidetti","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0070","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nbd.2006.02.011","article-title":"Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice","volume":"23","author":"Guidetti","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0085","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2990.2005.00655.x","article-title":"Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus","volume":"31","author":"Guillemin","year":"2005","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0095","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/glia.20090","article-title":"Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons","volume":"49","author":"Guillemin","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.expneurol.2013.08.007_bb0090","doi-asserted-by":"crossref","first-page":"12884","DOI":"10.1523\/JNEUROSCI.4101-07.2007","article-title":"Characterization of the kynurenine pathway in human neurons","volume":"27","author":"Guillemin","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0100","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0003-9861(67)90256-1","article-title":"Enzymic formation of d-kynurenine from d-tryptophan","volume":"120","author":"Higuchi","year":"1967","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0105","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1158\/0008-5472.CAN-06-2925","article-title":"Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses","volume":"67","author":"Hou","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0110","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/clinchem\/44.4.858","article-title":"Serum kynurenine-to-tryptophan ratio increases with progressive disease in HIV-infected patients","volume":"44","author":"Huengsberg","year":"1998","journal-title":"Clin. Chem."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0115","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.4049\/jimmunol.0803104","article-title":"Blockade of indoleamine 2,3-dioxygenase protects mice against lipopolysaccharide-induced endotoxin shock","volume":"182","author":"Jung","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1756-6606-2-8","article-title":"Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice","volume":"2","author":"Kanai","year":"2009","journal-title":"Mol. Brain"},{"key":"10.1016\/j.expneurol.2013.08.007_bb0125","doi-asserted-by":"crossref","first-page":"e11825","DOI":"10.1371\/journal.pone.0011825","article-title":"Psychological stress-induced, IDO1-dependent tryptophan catabolism: implications on immunosuppression in mice and humans","volume":"5","author":"Kiank","year":"2010","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.expneurol.2013.08.007_bb0230","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1172\/JCI61884","article-title":"Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression","volume":"122","author":"Kim","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0135","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F","article-title":"Enhanced sensitivity to N-methyl-d-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease","volume":"58","author":"Levine","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0145","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/hmg\/ddp527","article-title":"Expression analysis of novel striatal-enriched genes in Huntington disease","volume":"19","author":"Mazarei","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0235","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.12350","article-title":"Age-dependent alterations of the kynurenine pathway in the YAC128 mouse model of Huntington disease","author":"Mazarei","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0150","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.4049\/jimmunol.0802722","article-title":"Induction of IDO by bacille Calmette-Gu\u00e9rin is responsible for development of murine depressive-like behavior","volume":"182","author":"O'Connor","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0155","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nm.2056","article-title":"Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin","volume":"15","author":"Okamoto","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0160","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1073\/pnas.1117736109","article-title":"Tolerance to apoptotic cells is regulated by indoleamine 2,3-dioxygenase","volume":"109","author":"Ravishankar","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0165","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.expneurol.2005.07.004","article-title":"Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: implications for Huntington's disease","volume":"197","author":"Sapko","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0170","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1046\/j.1471-4159.1995.64020932.x","article-title":"Increased concentrations of the neurotoxin 3-hydroxykynurenine in the frontal cortex of HIV-1-positive patients","volume":"64","author":"Sardar","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0175","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.6849138","article-title":"Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain","volume":"219","author":"Schwarcz","year":"1983","journal-title":"Science"},{"issue":"1-2","key":"10.1016\/j.expneurol.2013.08.007_bb0240","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jns.2011.07.021","article-title":"Altered tryptophan metabolism in Parkinson's disease: a possible novel therapeutic approach","volume":"310","author":"Szab\u00f3","year":"2011","journal-title":"J. Neurol. Sci."},{"issue":"13","key":"10.1016\/j.expneurol.2013.08.007_bb0245","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.2174\/092986712800167365","article-title":"Mitochondrial disturbances, tryptophan metabolites and neurodegeneration: medicinal chemistry aspects","volume":"19","author":"Szalardy","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0190","doi-asserted-by":"crossref","first-page":"14912","DOI":"10.1073\/pnas.1203083109","article-title":"Delaying aging and the aging-associated decline in protein homeostasis by inhibition of tryptophan degradation","volume":"109","author":"van der Goot","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0250","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.expneurol.2013.08.007_bb0255","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nrd3793","article-title":"Kynurenines in the CNS: recent advances and new questions","volume":"12","author":"V\u00e9csei","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0205","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1189\/jlb.0705377","article-title":"Gene expression changes by amyloid beta peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes","volume":"79","author":"Walker","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0210","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s007020200014","article-title":"Increased neopterin production and tryptophan degradation in advanced Parkinson's disease","volume":"109","author":"Widner","year":"2002","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0215","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1471-4159.2009.06175.x","article-title":"Proinflammatory cytokine interferon-gamma increases induction of indoleamine 2,3-dioxygenase in monocytic cells primed with amyloid beta peptide 1\u201342: implications for the pathogenesis of Alzheimer's disease","volume":"110","author":"Yamada","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2013.08.007_bb0220","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cbpb.2009.02.002","article-title":"Characterization and evolution of vertebrate indoleamine 2, 3-dioxygenases IDOs from monotremes and marsupials","volume":"153","author":"Yuasa","year":"2009","journal-title":"Comp. Biochem. Physiol. B Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.expneurol.2013.08.007_bb0260","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.mcn.2003.11.014","article-title":"Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease","volume":"25","author":"Zeron","year":"2004","journal-title":"Mol. Cell. Neurosci."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488613002471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488613002471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T20:41:34Z","timestamp":1596400894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488613002471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":45,"alternative-id":["S0014488613002471"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2013.08.007","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The absence of indoleamine 2,3-dioxygenase expression protects against NMDA receptor-mediated excitotoxicity in mouse brain","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2013.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}